Abbott Laboratories
ABT124.845USD
+0.035+0.03%
종가 12/26, 16:00（ET）시세는 15분 지연됩니다
217.09B시가총액
15.54P/E TTM
자세한 내용은 Abbott Laboratories 회사
Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.
Abbott Laboratories 정보
종목 코드 ABT
회사 이름Abbott Laboratories
상장일Apr 06, 2073
CEOFord (Robert B)
직원 수114000
유형Ordinary Share
회계 연도 종료Apr 06
주소100 Abbott Park Road
도시ABBOTT PARK
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호60064-3500
전화12246676100
웹사이트https://www.abbott.com
종목 코드 ABT
상장일Apr 06, 2073
CEOFord (Robert B)
Abbott Laboratories의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-0.75%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+4.17%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
38.72K
+4.41%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
34.06K
-2.76%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Diabetes Care
1.98B
17.78%
Core Laboratory
1.36B
12.19%
Adult Nutritionals
1.16B
10.39%
Key Emerging Markets
1.06B
9.50%
Pediatric Nutritionals
1.05B
9.46%
기타
4.53B
40.67%
지역별USD
이름
수익
비율
All other Countries
6.87B
61.62%
United States
4.28B
38.38%
사업별
지역별
사업별USD
이름
수익
비율
Diabetes Care
1.98B
17.78%
Core Laboratory
1.36B
12.19%
Adult Nutritionals
1.16B
10.39%
Key Emerging Markets
1.06B
9.50%
Pediatric Nutritionals
1.05B
9.46%
기타
4.53B
40.67%
주식 보유 통계
마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
10.06%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Investment Management (US)
4.50%
Capital International Investors
3.54%
Capital Research Global Investors
2.23%
기타
74.54%
주주
주주
비율
The Vanguard Group, Inc.
10.06%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Investment Management (US)
4.50%
Capital International Investors
3.54%
Capital Research Global Investors
2.23%
기타
74.54%
주주 유형
주주
비율
Investment Advisor
47.15%
Investment Advisor/Hedge Fund
23.10%
Research Firm
3.49%
Pension Fund
2.34%
Bank and Trust
2.20%
Sovereign Wealth Fund
1.37%
Insurance Company
1.02%
Hedge Fund
0.49%
Individual Investor
0.48%
기타
18.36%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
4606
1.42B
81.82%
+3.92M
2025Q3
4681
1.42B
81.87%
+8.53M
2025Q2
4668
1.41B
81.51%
+6.23M
2025Q1
4636
1.40B
80.10%
+7.18M
2024Q4
4554
1.38B
78.81%
+33.68M
2024Q3
4367
1.35B
78.83%
-5.95M
2024Q2
4376
1.35B
78.36%
+5.03M
2024Q1
4375
1.35B
77.56%
-1.86M
2023Q4
4400
1.34B
77.62%
+7.10M
2023Q3
4258
1.33B
78.26%
-4.16M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
172.03M
9.88%
+2.96M
+1.75%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
88.52M
5.09%
+696.11K
+0.79%
Jun 30, 2025
State Street Investment Management (US)
78.35M
4.5%
+689.52K
+0.89%
Jun 30, 2025
Capital International Investors
60.14M
3.46%
-6.69M
-10.01%
Jun 30, 2025
Capital Research Global Investors
41.77M
2.4%
-8.97M
-17.68%
Jun 30, 2025
Geode Capital Management, L.L.C.
38.29M
2.2%
+1.39M
+3.77%
Jun 30, 2025
Wellington Management Company, LLP
25.05M
1.44%
-4.71M
-15.83%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
22.25M
1.28%
+1.27M
+6.03%
Jun 30, 2025
JP Morgan Asset Management
26.38M
1.52%
-2.42M
-8.39%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Wed, Nov 5
마지막 업데이트: Wed, Nov 5
이름
비율
iShares U.S. Medical Devices ETF
19.31%
Goldman Sachs Future Health Care Equity ETF
6.26%
SMI 3Fourteen Full-Cycle Trend ETF
5.01%
Invesco Pharmaceuticals ETF
4.99%
Health Care Select Sector SPDR Fund
4.62%
Proshares Ultra Health Care
4.61%
Tema Heart & Health ETF
4.5%
iShares U.S. Healthcare ETF
4.42%
AdvisorShares Focused Equity ETF
4.37%
Polen Capital Global Growth ETF
4.27%
더 보기
iShares U.S. Medical Devices ETF
비율19.31%
Goldman Sachs Future Health Care Equity ETF
비율6.26%
SMI 3Fourteen Full-Cycle Trend ETF
비율5.01%
Invesco Pharmaceuticals ETF
비율4.99%
Health Care Select Sector SPDR Fund
비율4.62%
Proshares Ultra Health Care
비율4.61%
Tema Heart & Health ETF
비율4.5%
iShares U.S. Healthcare ETF
비율4.42%
AdvisorShares Focused Equity ETF
비율4.37%
Polen Capital Global Growth ETF
비율4.27%
주식 배당금
지난 5년 동안 총
16.46B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Dec 12, 2025
ABT.NB Final Cash Dividend of gross USD 0.63 paid on Feb 13, 2026 going ex on Jan 15, 2026 with reinvestment option
Jan 15, 2026
Feb 13, 2026
Jan 15, 2026
Sep 19, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Nov 17, 2025 going ex on Oct 15, 2025 with reinvestment option
Oct 15, 2025
Nov 17, 2025
Oct 15, 2025
Jun 13, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Aug 15, 2025 going ex on Jul 15, 2025 with reinvestment option
Jul 15, 2025
Aug 15, 2025
Jul 15, 2025
Feb 21, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on May 15, 2025 going ex on Apr 15, 2025 with reinvestment option
Apr 15, 2025
May 15, 2025
Apr 15, 2025
Dec 13, 2024
ABT.NB Final Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
자주 묻는 질문
Abbott Laboratories의 상위 5대 주주는 누구인가요?
Abbott Laboratories의 상위 5대 주주는 다음과 같습니다:
The Vanguard Group, Inc.는 172.03M주의 주식을 보유하고 있으며, 전체 주식의 9.88%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 88.52M주의 주식을 보유하고 있으며, 전체 주식의 5.09%를 차지합니다.
State Street Investment Management (US)는 78.35M주의 주식을 보유하고 있으며, 전체 주식의 4.50%를 차지합니다.
Capital International Investors는 60.14M주의 주식을 보유하고 있으며, 전체 주식의 3.46%를 차지합니다.
Capital Research Global Investors는 41.77M주의 주식을 보유하고 있으며, 전체 주식의 2.40%를 차지합니다.
The Vanguard Group, Inc.는 172.03M주의 주식을 보유하고 있으며, 전체 주식의 9.88%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 88.52M주의 주식을 보유하고 있으며, 전체 주식의 5.09%를 차지합니다.
State Street Investment Management (US)는 78.35M주의 주식을 보유하고 있으며, 전체 주식의 4.50%를 차지합니다.
Capital International Investors는 60.14M주의 주식을 보유하고 있으며, 전체 주식의 3.46%를 차지합니다.
Capital Research Global Investors는 41.77M주의 주식을 보유하고 있으며, 전체 주식의 2.40%를 차지합니다.
Abbott Laboratories의 상위 3대 주주 유형은 무엇인가요?
Abbott Laboratories의 주요 주주 유형 상위 3가지는
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.
Abbott Laboratories(ABT)의 주식을 보유한 기관은 몇 개입니까?
2025Q4 기준으로, Abbott Laboratories의 주식을 보유한 기관은 총 4606곳이며, 이들이 보유한 주식의 총 가치는 약 1.42B로 전체 발행 주식의 81.82%를 차지합니다. 이는 2025Q3 대비 -0.05% 증가한 수치입니다.
Abbott Laboratories의 최대 수익원은 무엇인가요?
FY2025Q2 기준, Abbott Laboratories의 Diabetes Care 부문이 가장 높은 매출을 기록했으며, 금액은 1.98B로 전체 매출의 17.78%를 차지했습니다.
